You cannot transform what nobody can explain.
Artificial intelligence is common. Institutional intelligence is yours.
There is a system in your estate where one person’s retirement is a board-level risk. We capture what they know — from the code and from them — make it defensible enough to sign, and then put it to work.
The models were never the constraint. The knowledge they had to reason over was.
Every enterprise AI programme rests on one assumption nobody stress-tested: that what the machine needs to know is already written down. In the systems that actually run your company, it never was.
Every dollar you have spent on AI so far went to the fraction of your knowledge that somebody happened to document. The rest — the reasoning, the edge cases, the why — was never in the corpus, and no amount of model capability recovers it. This is not a gap in the technology. It is a missing floor underneath all of it.
There is now a whole category selling you the missing context — architectural maps of your codebase, indexes across your documents and applications. It is real work and it helps. But every one of those tools is built from what somebody already recorded. The reasoning that decides your edge cases was never recorded anywhere, and no connector reaches it. That is the part we go and get — from the people who still hold it, while they are still here.
Six problems running in life sciences right now — and the shape of the work that resolves each one.
No client names and no case studies. These are the situations we see repeatedly across regulated MedTech, and the form the work takes when IRIS is pointed at one of them. Each is a project you could scope on Monday. If one describes something sitting in your estate, that is the conversation.
Read the payer logic out of the platform that runs it
Write FDA-ready documentation from the firmware that ships
Delete the discovery phase of an ERP migration
Make the quality system explainable before an investigator asks
Understand an acquired platform before the people leave
Capture a retiring expert while they are still here
The questions that need three experts and a shared calendar.
No single function holds the answer. Today that means the decision waits for whoever is free.
A supplier change
One question — can we do this, what does it oblige us to file, what does it cost. The knowledge sits in three different heads, and the answer waits for whichever two are free on Thursday.
A 483 response
The finding spans manufacturing logic, quality workflow and design history. Four teams spend several weeks reassembling something the organisation already knew.
Day one after an acquisition
What does this platform do, what has it committed us to, and what breaks if we switch it off. Three questions, three functions, and nobody holds all three.
The point is not that we know more than your experts. It is that your organisation stops depending on which two of them are free on Thursday.
The knowledge is missing long before the programme admits it.
Discovery is a small share of a programme’s budget and a large share of its outcome. The published evidence is consistent on both halves.
FDA QMSR has been in force since 2 February 2026, incorporating ISO 13485:2016 by reference into 21 CFR Part 820. This is the first inspection cycle. Demonstrated system understanding is now something you get asked for — not something you plan for.
What IRIS reads
If your estate is written in one of these, it is in range. Volume is not the limiting factor — a million lines is ordinary.
And what it reads alongside the code
The written record is reconciled against the running system, so the two are compared rather than assumed.
And the part no tool reads: the people who still understand why it works that way.
Knowledge is not the deliverable. It is the precondition.
A specification nobody acts on is a better-organised archive. The reason to capture what your systems and your people know is that none of the work you actually want is possible until it exists — and most of it becomes straightforward once it does.
The migration that stops stalling in discovery
Design begins from a documented as-is instead of a blank page and twelve analysts in a room — and the as-is stays current through the programme rather than ageing out in month four.
The submission that stops waiting on two engineers
Traceability, hazard analysis and design rationale written from the firmware that actually ships, confirmed by the people who wrote it.
The audit you can answer in days
An investigator’s question met with provenance rather than an internal archaeology project across four teams.
The automation that finally has something true to run on
Agents acting on your real rules, with a citation behind every decision and a boundary around what they are allowed to do unattended.
Transformation is not blocked by ambition, and it is rarely blocked by budget. It is blocked by the fact that nobody can fully explain the thing being transformed.
Retrieve. Author. Monitor. Act.
Validated knowledge is the only kind that can be automated against in a regulated environment — because the action inherits the defensibility of the knowledge beneath it. The rungs cannot be skipped.
IRIS is deliberately bounded, and that boundary is what makes the intelligence defensible. The reviewer reviews rather than authors.
You are not buying knowledge. You are paying someone to re-derive what you already own.
It is in your source code and in your people, and it has been the whole time. Conventional discovery assembles a large integrator and your own scarce analysts into a room for weeks — and every hour spent there is an hour not spent running a live business. At the end you receive a document, and the understanding behind it leaves with the people who wrote it.
Every engagement you have ever run produced understanding that walked out of the building. This one leaves the asset behind, assigned to you.
Not a tool your team has to learn. Artifacts they can sign.
- A business specification of the system you namedReviewed and signed by your own analyst — who reviews rather than authors.
- Traceability from requirement to design to test to riskGenerated from what the system actually does, not from what the file says it does.
- A gap view against the standard that governs itQMSR, IEC 62304, ISO 14971, Annex 11 — as applicable.
- Provenance on every statementThe code path or the named expert it came from.
- The IP, assigned to you outrightAnd a named engineer’s signature on the deliverable.
Your reviewer confirms 80%+ specification accuracy — or the pilot has not succeeded. It is written into the SOW, not implied by it.
You will know whether this works before your next board review.
Inveris Digital is listed on AWS Marketplace. You can buy through your existing AWS agreement and draw it down against commitment you have already made — no new-vendor onboarding, no separate procurement cycle. For most enterprises this is the difference between starting this quarter and starting next year.
When not to call us.
If your systems are documented, your specifications match what is running, and the people who understand them are not going anywhere — you do not need us. That is a real answer, and it is more common than the market pretends. If two of those three are untrue, the conversation is worth thirty minutes.
Which of these is yours?
Pick the one that sounds like your week. It opens a short form — nothing you would need approval to share — and puts the right conversation in front of you instead of making you hunt for an email address.
Every one of these is a six-week question. Most people have been treating it as a six-month one.
The proof of concept costs you close to nothing, and it can be bought through AWS Marketplace against commitment you have already made — so the first step needs a decision, not a procurement cycle.